SCHEMBL6945754

SCHEMBL6945754

CN(C)Cc1c[nH]c2ccc(Cn3ccnc3)cc12

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 7/20 0.79
HTR2C P28335 5/20 0.79
TBXAS1 P24557 4/20 0.58
CYP19A1 P11511 4/20 0.53
MEN1 O00255 2/20 0.53
KMT2A Q03164 2/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
HTR1D P28221 2/20 0.51
HTR1B P28222 2/20 0.51
ADRA2C P18825 1/20 0.51
HTR2A P28223 1/20 0.51
HRH1 P35367 1/20 0.51
HTR2B P41595 1/20 0.51
SNCA P37840 1/20 0.50
CYP11B1 P15538 2/20 0.45
CYP11B2 P19099 2/20 0.45
KDM4E B2RXH2 1/20 0.45
ALDH1A1 P00352 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2D6 P10635 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6943873 0.88 HTR1A (1.00) HTR1AHTR2CTBXAS1HTR1DHTR1B
SCHEMBL6941388 0.85 HTR1A (0.58) HTR1AHTR2CMEN1KMT2AHTR1D
SCHEMBL7076434 0.83 HTR1A (0.82) HTR1AHTR2CTBXAS1CYP19A1MEN1
SCHEMBL7480332 0.82 HTR2C (0.73) HTR1AHTR2CTBXAS1CYP19A1MEN1
SCHEMBL27374776 0.81 HTR1A (0.75) HTR1AHTR2CTBXAS1CYP19A1MEN1
SCHEMBL7478876 0.80 HTR1A (0.71) HTR1AHTR2CTBXAS1CYP19A1MEN1
SCHEMBL6943909 0.79 HTR1A (0.79) HTR1AHTR2CMEN1KMT2AHTR1D
SCHEMBL11488027 0.78 TBXAS1 (0.67) HTR1AHTR2CTBXAS1CYP19A1MEN1
SCHEMBL11488802 0.76 TBXAS1 (0.72) HTR1AHTR2CTBXAS1CYP19A1MEN1
SCHEMBL3029512 0.75 HTR1A (0.73) HTR1AHTR2CMEN1KMT2AHTR1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0925302-B1 PALLADIUM CATALYZED INDOLIZATION MERCK & CO INC (US) 2002-11-20 EP claimed
CN-1322725-A Indole derivant MERCK & CO INC (US) 2001-11-21 CN claimed
CN-1228094-A Palladium catalyzed indolization MERCK & CO INC (US) 1999-09-08 CN claimed
EP-0925302-A1 PALLADIUM CATALYZED INDOLIZATION Merck & Co., Inc. (US) 1999-06-30 EP claimed
WO-1998006725-A1 PALLADIUM CATALYZED INDOLIZATION MERCK & CO., INC. (US) 1998-02-19 WO claimed
CN-1152920-A Palladium-Catalyzed Ring Closure of Triazolyl Tryptamine MERCK & CO INC (US) 1997-06-25 CN claimed
US-5567824-A CATALYZING THE CYCLIZATION IN PRESENCE OF A SOLVENT AND A PROTON ACCEPTOR MERCK & CO., INC. (US) 1996-10-22 US claimed
CN-1157390-C Indole derivant 2004-07-14 CN disclosed
EP-0763032-B1 PALLADIUM CATALYZED RING CLOSURE OF TRIAZOLYL TRYPTAMINE MERCK & CO INC (US) 2003-10-15 EP disclosed
EP-0925302-B1 PALLADIUM CATALYZED INDOLIZATION MERCK & CO INC (US) 2002-11-20 EP disclosed
CN-1084751-C Palladium catalyzed indolization MERCK & CO INC (US) 2002-05-15 CN disclosed
CN-1077104-C Palladium-Catalyzed Ring Closure of Triazolyl Tryptamine MERCK & CO INC (US) 2002-01-02 CN disclosed
CN-1322725-A Indole derivant MERCK & CO INC (US) 2001-11-21 CN disclosed
CN-1228094-A Palladium catalyzed indolization MERCK & CO INC (US) 1999-09-08 CN disclosed
CN-1152920-A Palladium-Catalyzed Ring Closure of Triazolyl Tryptamine MERCK & CO INC (US) 1997-06-25 CN disclosed
US-5567824-A CATALYZING THE CYCLIZATION IN PRESENCE OF A SOLVENT AND A PROTON ACCEPTOR MERCK & CO., INC. (US) 1996-10-22 US disclosed